Lactate lactylation is a novel post-translational modification (PTM) where lactate-derived lactyl groups are covalently attached to lysine residues on histone and non-histone proteins. This modification represents a crucial link between cellular metabolism and epigenetic regulation, with emerging evidence for its role in neurodegenerative diseases.
Historically viewed as merely a metabolic byproduct of anaerobic glycolysis, lactate has been redefined as a vital signaling molecule that bridges energy metabolism with gene regulation. Lactylation (Kla) was first described in 2019 as a new type of histone modification, and subsequent research has revealed its broad involvement in various biological processes including neuroprotection and neurodegeneration [1](https://pubmed.ncbi.nlm.nih.gov/40537007/).
The modification involves the transfer of a lactyl group from lactyl-CoA to lysine residues, creating a reversible epigenetic mark that can be dynamically regulated by specific writer and eraser enzymes. This process allows cells to adapt gene expression programs in response to metabolic states.
The enzymes responsible for adding lactyl groups to proteins include:
Lactate lactylation is a novel post-translational modification (PTM) where lactate-derived lactyl groups are covalently attached to lysine residues on histone and non-histone proteins. This modification represents a crucial link between cellular metabolism and epigenetic regulation, with emerging evidence for its role in neurodegenerative diseases.
Historically viewed as merely a metabolic byproduct of anaerobic glycolysis, lactate has been redefined as a vital signaling molecule that bridges energy metabolism with gene regulation. Lactylation (Kla) was first described in 2019 as a new type of histone modification, and subsequent research has revealed its broad involvement in various biological processes including neuroprotection and neurodegeneration [1](https://pubmed.ncbi.nlm.nih.gov/40537007/).
The modification involves the transfer of a lactyl group from lactyl-CoA to lysine residues, creating a reversible epigenetic mark that can be dynamically regulated by specific writer and eraser enzymes. This process allows cells to adapt gene expression programs in response to metabolic states.
The enzymes responsible for adding lactyl groups to proteins include:
| Enzyme | Full Name | Function |
|--------|-----------|----------|
| p300 | EP300 | Major histone acetyltransferase that also exhibits lactyltransferase activity |
| GCN5 | KAT2B | Histone acetyltransferase with confirmed lactylation activity |
| HBO1 | KAT7 | Histone acetyltransferase involved in lactylation |
| KAT8 | KAT8 | Histone acetyltransferase contributing to protein lactylation |
These writers primarily target lysine residues on histone proteins (particularly H3K18la and H3K9la) but also modify non-histone proteins involved in key cellular processes.
Lactylation is a reversible modification removed by specific delactylases:
| Enzyme | Full Name | Class |
|--------|-----------|-------|
| HDAC1 | Histone Deacetylase 1 | Class I HDAC |
| HDAC2 | Histone Deacetylase 2 | Class I HDAC |
| HDAC3 | Histone Deacetylase 3 | Class I HDAC |
| HDAC8 | Histone Deacetylase 8 | Class I HDAC |
| SIRT1 | Sirtuin 1 | Class III HDAC (NAD-dependent) |
| SIRT2 | Sirtuin 2 | Class III HDAC (NAD-dependent) |
| SIRT3 | Sirtuin 3 | Class III HDAC (NAD-dependent) |
The sirtuin family (SIRT1-3) is particularly relevant in neurodegeneration due to their well-documented neuroprotective functions and NAD+-dependent mechanism linking cellular energy status to protein modification.
The primary reader identified for lactylation includes:
In Alzheimer's disease (AD), lactylation is emerging as a significant regulatory mechanism:
Beyond AD and PD, lactylation is implicated in:
The metabolic pathway leading to protein lactylation involves several key enzymatic steps:
Lactate Dehydrogenase (LDH): LDH converts pyruvate to lactate while generating NAD+. This reaction is reversible, allowing bidirectional conversion based on cellular energy needs[@wang2019].
Acyl-CoA Synthetases: Multiple acyl-CoA synthetases (ACSs) can convert lactate to lactyl-CoA, the immediate substrate for lactylation. The acyl-CoA synthetase family member ACSL4 shows particular activity toward lactate[@zhang2023].
Cellular Lactate Pools: The cellular lactate concentration determines the rate of lactyl-CoA formation. Under conditions of high glycolysis or hypoxia, lactate accumulates and drives lactylation[@liu2024b].
Lysine Recognition: The lactyltransferase enzymes recognize specific lysine residues based on local sequence context and chromatin accessibility. H3K18 and H3K9 represent major lactylation sites with functional significance in gene regulation[@yang2023].
Lactyl Group Transfer: The transfer mechanism involves formation of a lactyl-enzyme intermediate followed by nucleophilic attack by the lysine ε-amino group, similar to acetylation chemistry.
Transcriptional Activation: Lactylation correlates with active transcription at specific genomic loci. H3K18la marks active promoters and enhancers in neurons, suggesting a role in activity-dependent gene expression[@yang2023].
Alternative to Acetylation: Lactylation can occur on the same lysine residues as acetylation, providing a metabolic alternative to the classic epigenetic mark. The balance between acetylation and lactylation responds to cellular metabolic state.
In Alzheimer's disease, lactylation participates in multiple pathological processes:
Amyloid Processing: Histone lactylation affects transcription of APP and the secretase enzymes (BACE1, PS1)[@gu2024]. Altered lactylation in AD brains may contribute to dysregulated amyloid processing.
Tau Phosphorylation: The lactylation-dependent transcriptional program includes genes encoding tau kinases and phosphatases. Reduced lactylation of promoters for tau-modifying enzymes correlates with increased tau pathology[@gao2024].
Microglial Activation: Lactylation modulates microglial phenotype through transcriptional regulation of inflammatory genes. Pro-inflammatory microglia show decreased global lactylation compared to homeostatic counterparts[@xu2024].
Energy Metabolism Link: The well-documented glucose hypometabolism in AD provides a mechanistic link to lactylation. Reduced glycolysis leads to decreased lactate and lactylation in AD neurons[@li2024].
In Parkinson's disease, lactylation affects dopaminergic neuron function:
Alpha-Synuclein Regulation: Lactylation influences SNCA gene expression and may affect alpha-synuclein aggregation propensity[@huang2024].
Mitochondrial Quality Control: The transcription of PGC-1α and other mitochondrial biogenesis regulators is modulated by lactylation, affecting dopaminergic neuron resilience.
L-DOPA Metabolism: Long-term L-DOPA treatment may affect cellular lactate dynamics and lactylation patterns in PD patients[@huang2024].
Lactylation plays complex roles in acute brain injury:
Ischemic Tolerance: Preconditioning with lactate or lactate-increasing interventions provides neuroprotection through enhanced lactylation[@zhao2023].
Reperfusion Injury: Lactate accumulation during reperfusion drives aberrant lactylation that may contribute to secondary injury.
Therapeutic Potential: Exogenous lactate administration shows promise in stroke models through lactylation-dependent mechanisms[@he2024].
In demyelinating diseases, lactylation affects oligodendrocyte function:
Remyelination: Lactylation promotes oligodendrocyte precursor cell differentiation and remyelination[@fan2023].
Myelin Maintenance: The myelin maintenance program is regulated by lactylation enzymes.
Lactate Infusion: Acute lactate infusion improves cognition in aged individuals and animal models[@chen2024]. The mechanism involves enhanced histone lactylation at memory-related genes.
Lactate Precursors: Dichloroacetate and other pyruvate dehydrogenase activators increase lactate availability for lactylation.
Exercise Mimetics: Pharmacological exercise mimetics that increase lactate also enhance neuroprotective lactylation[@chen2024].
Ketogenic Diet: Ketogenic diet increases histone lactylation through multiple mechanisms[@zhang2024b]:
Calorie Restriction: Long-term calorie restriction modulates lactylation patterns in the aging brain.
SIRT1 Activators: SIRT1 activators (resveratrol, SRT2183) promote delactylation with potential neuroprotective effects[@liu2023].
HDAC Inhibitors: Both classical HDAC inhibitors and SIRT1 activators alter global lactylation patterns through overlapping substrate specificity[@fan2023].
p300 Modulators: p300 inhibitors reduce aberrant lactylation while activators may enhance protective lactylation.
The hippocampus shows particularly dynamic lactylation:
Memory Formation: Activity-dependent lactate release during learning enhances hippocampal lactylation[@yang2023].
Aging Effects: Age-related cognitive decline correlates with reduced hippocampal lactylation[@chen2024].
AD Vulnerability: The hippocampus shows early lactylation changes in AD models.
Cortical lactylation differs by layer and cell type:
Neurons vs. Astrocytes: Astrocytes show higher baseline lactylation than neurons due to their glycolytic metabolism.
Layer-Specific Patterns: Different cortical layers show distinct lactylation signatures.
Dopaminergic neurons have unique lactylation:
Metabolic Demands: High energy requirements of dopaminergic neurons affect lactylation.
Vulnerability: The substantia nigra shows age-related lactylation changes that may contribute to PD vulnerability.
CSF Lactate: Cerebrospinal fluid lactate levels may serve as a proxy for brain lactylation activity in some conditions[@liu2024b].
Peripheral Markers: Blood-based lactylation signatures remain under investigation.
Lactate Imaging: MR spectroscopy can measure brain lactate non-invasively.
Epigenetic Signatures: Blood cell lactylation correlates with brain lactylation in some studies.
This mechanism intersects with several key NeuroWiki pathways:
🟡 Moderate-High Confidence
| Dimension | Score |
|-----------|-------|
| Supporting Studies | 20+ references |
| Replication | Growing evidence |
| Effect Sizes | Moderate |
| Contradicting Evidence | Limited |
| Mechanistic Completeness | 60% |
Overall Confidence: 65%
The aging brain shows significant alterations in lactylation:
Global Reduction: Global histone lactylation decreases with age in both human and mouse brains[@chen2024]. This reduction correlates with age-related cognitive decline.
Specific Site Changes: Different lactylation sites show distinct aging patterns. Some sites increase while others decrease with age.
Functional Consequences: Reduced lactylation at memory-related genes correlates with impaired cognitive performance in aged individuals.
Exercise: Regular exercise counteracts age-related lactylation changes through increased lactate availability[@chen2024].
Calorie Restriction: Calorie restriction maintains youthful lactylation patterns in aging brains.
Pharmacological: SIRT1 activators and HDAC inhibitors show potential for modulating age-related lactylation changes.
The astrocyte-neuron lactate shuttle (ANLS) represents a key metabolic circuit:
Astrocyte Glycolysis: Astrocytes preferentially metabolize glucose to lactate through aerobic glycolysis.
Lactate Release: Astrocytes release lactate through monocarboxylate transporters (MCTs).
Neuronal Uptake: Neurons take up lactate and use it as an alternative energy substrate.
Cognitive Function: The lactate shuttle supports cognitive function under challenging conditions[@wu2023].
Metabolic Coupling: The ANLS provides lactate for neuronal lactylation during activity.
Astrocyte Regulation: Astrocyte lactylation affects the metabolic support provided to neurons.
Dysfunction in Disease: Impaired ANLS contributes to neurodegeneration through reduced neuronal lactylation.
Cell-Type Specificity: Understanding lactylation in specific cell types remains challenging.
Dynamic Regulation: Real-time visualization of lactylation in vivo is needed.
Causal vs. Correlational: Determining whether lactylation changes are causal or correlational in neurodegeneration.
Biomarker Development: Lactylation signatures as biomarkers for diagnosis and treatment monitoring.
Personalized Medicine: Genetic variants affecting lactylation enzymes for personalized approaches.
Combination Therapies: Combining lactylation-targeted approaches with other therapeutic strategies.
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
The following diagram shows the key molecular relationships involving Lactate Lactylation in Neurodegeneration discovered through SciDEX knowledge graph analysis: